Vanguard PRIMECAP Inv (VPMCX)
138.76
-0.88 -0.63%
Aug 11
USD
Key Stats
| Expense Ratio | 0.38% |
| Total Assets Under Management | 62.60B |
| Share Class Assets Under Management | 5.866B |
| Net Asset Value | 138.76 |
| Turnover Ratio | 5.00% |
| 1 Year Fund Level Flows | -6.647B |
Performance & Returns
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 2.75% | 2.58% | 45 |
| 3M | 13.55% | 15.84% | 82 |
| 6M | -3.73% | 8.54% | 96 |
| YTD | -0.26% | 15.78% | 96 |
| 1Y | 13.28% | 26.25% | 90 |
| 3Y | 12.47% | 18.19% | 88 |
| 5Y | 12.51% | 14.04% | 68 |
| 10Y | 15.03% | 15.33% | 58 |
| 15Y | 10.74% | 10.13% | 38 |
| 20Y | 7.90% | 6.28% | 16 |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 2.60% | 2.60% | 0.00% |
| Stock | 97.40% | 97.40% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
Region Exposure
| Americas | 83.19% |
| North America | 83.19% |
| Latin America | 0.00% |
| Greater Europe | 11.03% |
| United Kingdom | 2.61% |
| Europe Developed | 8.42% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 5.78% |
| Japan | 1.86% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 3.92% |
| Market Classification | |
| % Developed Markets | 96.08% |
| % Emerging Markets | 3.92% |
Stock Sector Exposure
| Basic Materials | 0.64% |
| Communication Services | 6.76% |
| Consumer Cyclical | 8.80% |
| Consumer Defensive | 0.03% |
| Energy | 0.85% |
| Financial Services | 7.97% |
| Healthcare | 30.61% |
| Industrials | 13.52% |
| Real Estate | 0.00% |
| Technology | 30.82% |
| Utilities | 0.00% |
Stock Market Capitalization
| Giant | 52.26% |
| Large | 34.66% |
| Medium | 12.25% |
| Small | 0.75% |
| Micro | 0.07% |
Stock Style Exposure
| Large Cap Value | 23.79% |
| Large Cap Blend | 30.71% |
| Large Cap Growth | 32.63% |
| Mid Cap Value | 8.11% |
| Mid Cap Blend | 1.49% |
| Mid Cap Growth | 2.45% |
| Small Cap Value | 0.35% |
| Small Cap Blend | 0.47% |
| Small Cap Growth | 0.00% |
View More Holdings
As of March 31, 2020
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| LLY | Eli Lilly and Co | 5.84% | 152.75 | +1.41% |
| BIIB | Biogen Inc | 5.47% | 293.47 | +1.22% |
| ADBE | Adobe Inc | 5.28% | 444.99 | +2.24% |
| MSFT | Microsoft Corp | 4.96% | 208.77 | +2.65% |
| AMGN | Amgen Inc | 3.99% | 241.20 | +2.79% |
| TXN | Texas Instruments Inc | 3.31% | 138.63 | +1.90% |
| BABA | Alibaba Group Holding Ltd ADR | 2.97% | 254.74 | +2.54% |
| MU | Micron Technology Inc | 2.39% | 47.48 | -0.59% |
| AZN | AstraZeneca PLC ADR | 2.38% | 56.85 | +3.03% |
| LUV | Southwest Airlines Co | 2.23% | 35.16 | -0.37% |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. | |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Growth |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Alfred Mordecai | 20.60 yrs |
| James Marchetti | 5.51 yrs |
| Joel Fried | 31.61 yrs |
| M. Ansari | 12.59 yrs |
| Theo Kolokotrones | 35.19 yrs |
Share Classes
| Symbol | Share Class |
|---|---|
| VPMAX | Inst |
Net Fund Flows
| 1M | -761.76M |
| 3M | -1.910B |
| 6M | -3.753B |
| YTD | -4.187B |
| 1Y | -6.647B |
| 3Y | -10.94B |
| 5Y | -14.51B |
| 10Y | -22.50B |
Risk Info
| Beta (5Y) | 1.008 |
| Historical Sharpe Ratio (10Y) | 0.9771 |
| Historical Sortino (All) | 0.9644 |
| Daily Value at Risk (VaR) 1% (All) | 3.15% |
| Monthly Value at Risk (VaR) 1% (All) | 14.49% |
Fundamentals
| Dividend Yield TTM (8-11-20) | 1.22% |
| 30-Day SEC Yield (8-11-20) | 0.87% |
| 7-Day SEC Yield (11-28-03) | 0.00% |
| Weighted Average PE Ratio | 14.80 |
| Weighted Average Price to Sales Ratio | 1.662 |
| Weighted Average Price to Book Ratio | 2.993 |
| Weighted Median ROE | 31.76% |
| Weighted Median ROA | 11.13% |
| Forecasted Dividend Yield | 2.11% |
| Forecasted PE Ratio | 15.12 |
| Forecasted Price to Sales Ratio | 1.504 |
| Forecasted Price to Book Ratio | 2.842 |
| Number of Holdings | 145 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.40% |
| Forecasted Book Value Growth | 3.80% |
| Forecasted Cash Flow Growth | 9.88% |
| Forecasted Earnings Growth | 11.01% |
| Forecasted Revenue Growth | 7.83% |
Attributes
| Purchase Details | |
|---|---|
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | 3000.00 USD |
| Minimum Subsequent Investment | 1.00 USD |
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.37% |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| Key Dates | |
| Inception Date | 11/1/1984 |
| Termination Date | |
| Last Annual Report Date | 9/30/2019 |
| Last Prospectus Date | 1/31/2020 |
| Attributes | |
| Exchange Traded Share | No |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
